Tilray Brands (TSE:TLRY) Trading Down 7.6% - Should You Sell?

Key Points

• Tilray Brands shares recently fell by 7.6% to trade at C$1.45, with trading volume increasing by 20% compared to its average.
• The company's current ratio stands at 2.54, while its debt-to-equity ratio is notably high at 10.76, indicating potential financial risks.
• Tilray is a major player in the Canadian cannabis market, having been formed from a merger of legacy brands Aphria and Tilray in 2021.

Shares of Tilray Brands, Inc. (TSE:TLRY - Get Free Report) were down 7.6% on Tuesday . The stock traded as low as C$1.43 and last traded at C$1.45. Approximately 2,357,418 shares were traded during mid-day trading, an increase of 20% from the average daily volume of 1,966,315 shares. The stock had previously closed at C$1.57.

Tilray Brands Trading Up 5.4%

The company has a debt-to-equity ratio of 10.76, a current ratio of 2.54 and a quick ratio of 2.16. The business's 50-day moving average price is C$0.86 and its 200-day moving average price is C$0.86. The firm has a market capitalization of C$998.77 million, a PE ratio of -3.75 and a beta of 2.19.

About Tilray Brands

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.